Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.73 |
| ▸ | ACHE | P22303 | 3/20 | 0.55 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.46 |
| ▸ | CYP2C8 | P10632 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP4B1 | P13584 | 2/20 | 0.46 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.46 |
| ▸ | CYP3A5 | P20815 | 2/20 | 0.46 |
| ▸ | CYP2A7 | P20853 | 2/20 | 0.46 |
| ▸ | CYP3A7 | P24462 | 2/20 | 0.46 |
| ▸ | CYP2F1 | P24903 | 2/20 | 0.46 |
| ▸ | CYP2C18 | P33260 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP2J2 | P51589 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL145855 | 0.93 | ALDH1A1 (0.62) | ALDH1A1ACHECYP1A1CYP1B1CYP3A4 | |
| SCHEMBL29587173 | 0.90 | ALDH1A1 (0.59) | ALDH1A1ACHECYP1A1CYP1B1CYP3A4 | |
| 1,3,5-Trimethoxybenzene SCHEMBL28493 | 0.86 | ALDH1A1 (1.00) | ALDH1A1CYP1A1CYP1B1CYP3A4CYP1A2 | |
| SCHEMBL2952197 | 0.85 | ALDH1A1 (0.53) | ALDH1A1ACHECYP1A1CYP1B1CYP3A4 | |
| Hexane SCHEMBL28393141 | 0.84 | ALDH1A1 (0.52) | ALDH1A1ACHECYP1A1CYP1B1CYP3A4 | |
| SCHEMBL14120989 | 0.84 | ALDH1A1 (0.52) | ALDH1A1ACHECYP1A1CYP1B1CYP3A4 | |
| SCHEMBL4342018 | 0.83 | ALDH1A1 (0.50) | ALDH1A1ACHECYP1A1CYP1B1CYP3A4 | |
| SCHEMBL14461578 | 0.83 | ESR1 (0.52) | ALDH1A1ACHECYP1A1CYP1B1CYP3A4 | |
| SCHEMBL14446349 | 0.83 | ALDH1A1 (0.50) | ALDH1A1ACHECYP1A1CYP1B1CYP3A4 | |
| SCHEMBL16362233 | 0.83 | CYP1A1 (0.77) | CYP1A1CYP1B1CYP1A2ABL1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1712 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118812487-A | Synthetic method and application of deuterated alternariol monomethyl ether | 青岛普瑞邦生物工程有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118549575-A | Detection method of fingerprint spectrum of chemical components in nasosinusitis oral liquid volatile oil, establishment method of fingerprint spectrum and application of fingerprint spectrum | 成都华神科技集团股份有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-118239883-A | Preparation method of lysine-specific demethylase 1 (LSD 1) inhibitor | 江苏联环药业股份有限公司 | 2024-06-25 | — | — | CN | claimed |
| CN-113046179-B | Dendrobium officinale flower fragrance composition and preparation method and application thereof | 中国科学院昆明植物研究所 | 2023-06-06 | — | — | CN | claimed |
| US-20230131260-A1 | SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS | SYNGENTA CROP PROTECTION AG (CH) | 2023-04-27 | — | — | US | claimed |
| CN-114052017-B | Application of 3,5-dimethoxytoluene in poisoning nematodes and nematode poisoning agent containing same | 吉林农业大学 | 2023-03-14 | — | — | CN | claimed |
| CN-115650926-A | Azole selenone functional reagent and application thereof | 华南农业大学 | 2023-01-31 | — | — | CN | claimed |
| CN-111912923-B | Method for detecting volatile components in medicinal preparation | 山东步长制药股份有限公司 | 2022-12-02 | — | — | CN | claimed |
| US-11274083-B2 | Substituted thiophenyl uracils, salts thereof and the use thereof as herbicidal agents | SYNGENTA CROP PROTECTION AG (CH) | 2022-03-15 | — | — | US | claimed |
| CN-114052017-A | Application of 3,5-dimethoxytoluene in poisoning nematodes and nematode poisoning agent containing same | 吉林农业大学 | 2022-02-18 | — | — | CN | claimed |
| US-20050124614-A1 | 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis | AXYS PHARMACEUTICALS, INC. (US) | 2005-06-09 | — | — | US | claimed |
| WO-2004004727-A1 | 3,4-DIHYDROISOQUINOLIN-1-ONE DERIVATIVES AS INDUCERS OF APOPTOSIS | AXYS PHARMACEUTICALS, INC. (US) | 2004-01-15 | — | — | WO | claimed |
| US-6495540-B2 | HEXAHYDROAZEPINE-2-ONE DERIVATIVE AS BETA-AMYLOID INHIBITOR | BRISTOL - MYERS SQUIBB PHARMA COMPANY | 2002-12-17 | — | — | US | claimed |
| CN-1378460-A | Skin immune function controlling agents | SHISEIDO CO LTD (JP) | 2002-11-06 | — | — | CN | claimed |
| EP-1224944-A1 | SKIN IMMUNE FUNCTION CONTROLLING AGENTS | SHISEIDO COMPANY LIMITED (JP) | 2002-07-24 | — | — | EP | claimed |
| US-20020010172-A1 | Lactams as inhibitors of A-beta protein production | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2002-01-24 | — | — | US | claimed |
| EP-1147079-A2 | BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS | Bayer Aktiengesellschaft (DE) | 2001-10-24 | — | — | EP | claimed |
| US-6268333-B1 | BLEND WITH 1,3-DIMETHOXY-5-METHYLBENZENE; STIMULATIVE COMPONENT IS A JASMINE FORMULATION. | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2001-07-31 | — | — | US | claimed |
| WO-2000041469-A2 | β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-07-20 | — | — | WO | claimed |
| US-6060453-A | Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose | GREENWICH PHARMACEUTICALS INCORPORATED (US) | 2000-05-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11274083-B2 | Substituted thiophenyl uracils, salts thereof and the use thereof as herbicidal agents | UNG, TYMP, TYMS | ALDH1A1 133/4885ACHE 1888/4885CYP1A1 752/4885 |
| US-20050124614-A1 | 3,4-Dihydroisoquinolin-1-one derivatives as inducers of apoptosis | CASP3, BAX, BAD | ALDH1A1 1368/4885ACHE 3732/4885CYP1A1 402/4885 |
| US-20020010172-A1 | Lactams as inhibitors of A-beta protein production | BACE1, APP, APH1A | ALDH1A1 3399/4885ACHE 62/4885CYP1A1 2014/4885 |
| US-20230131260-A1 | SUBSTITUTED THIOPHENYL URACILS, SALTS THEREOF AND THE USE THEREOF AS HERBICIDAL AGENTS | UNG, TYMP, TYMS | ALDH1A1 170/4885ACHE 1932/4885CYP1A1 959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.